Epicardial adipose tissue volume is associated with impaired left ventricular strain in patients with metabolic syndrome: the mediating role of myocardial energetic efficiency

Cardiovasc DiabetolPublished Cross-sectional study

Authors' conclusion

In patients with metabolic syndrome, increased EATV was independently associated with impaired LV myocardial strain, with reduced MEEI partly explaining the observed EATV-LV dysfunction association.

Study context

Population
Patients with metabolic syndrome and age- and sex-matched controls undergoing cardiac magnetic resonance (CMR)
Participants
225 vs 68
Exposure
Metabolic syndrome (MetS) patients vs matched controls; association of epicardial adipose tissue volume (EATV) with left ventricular (LV) strain mediated by myocardial energetic efficiency index (MEEI)
  • MetSn = 225
  • Controlsn = 68reference
Outcome
Direct and MEEI-mediated effects of EATV on LV myocardial strain
Methodological detailsage- and sex-matched controls, cardiac magnetic resonance, mediation analysis
  • Age- and sex-matched controls
  • Cardiac magnetic resonance
  • Mediation analysis

Main finding

As reported in the abstract

EATV, MEEI and LV myocardial strain
EATV correlation with MEEI
r = - 0.224, P < 0.001
EATV correlation with LV peak strain in all three directions
r = - 0.174 to - 0.332, P < 0.01
EATV independent predictor of lower LV GLPS (multivariable regression)
β = - 0.178, P = 0.01
EATV independent predictor of lower MEEI (multivariable regression)
β = - 0.268, P < 0.01
Share of total negative effect of EATV on GLPS accounted for by reduced MEEI
≈29%
Standardized indirect effect of EATV on GLPS via MEEI
β = - 0.081, 95% CI - 0.137 to - 0.0029, P < 0.01

Observational data: associations, not effects.

Further findings

MetS patients had impaired myocardial strain and lower MEEI vs controls

Original publication

Epicardial adipose tissue volume is associated with impaired left ventricular strain in patients with metabolic syndrome: the mediating role of myocardial energetic efficiency. Cardiovasc Diabetol. Published 9 August 2025. doi:10.1186/s12933-025-02859-6

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.